Literature DB >> 21975657

Universal acquired melanosis in siblings.

Snehansu Chakraborti1, Tarak Nath Ghosh, Shankha Subhra Nag, Arvind Kumar Singh, Piyali Mitra.   

Abstract

Generalized pigmentation in a child may be seen in a variety of disorders which can be clinically differentiated. Accuracy of diagnosis can be increased by classifications based on both clinical and histological findings. The authors report a case of siblings in whom hyperpigmentation started at age of about 6 mo and was progressing. Histology of skin revealed shortening and blunting of rete ridges with presence of melanocytes in stratum basal layer. This is a rare type of hypermelanosis and termed as universal acquired melanosis or carbon baby syndrome. This is a rare presentation and first case report in siblings.

Entities:  

Mesh:

Year:  2012        PMID: 21975657     DOI: 10.1007/s12098-011-0576-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  6 in total

1.  Familial progressive hypermelanosis in Indian monozygotic twins.

Authors:  Neerja Gupta; Mehar Chand Sharma; M Ramam; Madhulika Kabra
Journal:  Pediatr Dermatol       Date:  2011-01-25       Impact factor: 1.588

Review 2.  Diffuse hyperpigmentation of the skin: a clinicopathologic approach to diagnosis.

Authors:  C M Stefanato; J Bhawan
Journal:  Semin Cutan Med Surg       Date:  1997-03

3.  Universal inherited melanodyschromatosis: a case of melanosis universalis hereditaria?

Authors:  A Rebora; A Parodi
Journal:  Arch Dermatol       Date:  1989-10

4.  Familial progressive hyperpigmentation.

Authors:  M E Chernosky; D E Anderson; J P Chang; M W Shaw; M M Romsdahl
Journal:  Arch Dermatol       Date:  1971-06

5.  Universal acquired melanosis. The carbon baby.

Authors:  R Ruiz-Maldonado; L Tamayo; J Fernández-Diez
Journal:  Arch Dermatol       Date:  1978-05

6.  [Congenital diffuse melanosis].

Authors:  A Kint; C Oomen; M L Geerts; F Breuillard
Journal:  Ann Dermatol Venereol       Date:  1987       Impact factor: 0.777

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.